THE EUROCHIP PROJECTS Health Indicators for Health Indicators for Monitoring Cancer in Europe

Slides:



Advertisements
Similar presentations
Health in Prisons Project Establishing a Monitoring Mechanism on Prison Health Indicators and Health Determinants Working Party on Information on Lifestyle.
Advertisements

EUROCHIP-3 WORK PACKAGES. MAIN WORK PACKAGES of EUROCHIP-3 Ahti Anttila Adherence to cervical screening in 5 Eastern EU countries Renée Otter Population-based.
EUROCHIP-3: WP-4 Publications Paolo Baili Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
The importance of cancer data & registries to understand the cancer burden (EUROCHIP) ECPC Cancer Summit 2010, October 2010 Dr. Andrea Micheli Director.
BY CALVIN ROBERSON JR, MPH, MHA VICE PRESIDENT OF PLANNING & PROGRAM DEVELOPMENT State Master Research Plan.
Dr Andrea Micheli Descriptive Epidemiology and Health Planning Unit Fondazione IRCCS “Istituto Nazionale dei Tumori” Milan Public Health Programme EUROPEAN.
FROM EUROCHIP-1 TO EUROCHIP-2 EUROCHIP-2 - The action Public Health Program EUROPEAN COMMISSION: HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL.
Public Health Programme EUROPEAN COMMISSION: HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL EUROCHIP-3 WP-4 Update EUROCHIP: EUROpean Cancer Health Indicator.
European Partnership for Action Against Cancer (EPAAC)
EUROCHIP-2 the action Health Indicators for Monitoring Cancer in Europe Public Health Program EUROPEAN.
EUROCHIP - EUROpean Cancer Health Indicators Project A fight against disequalities in managing cancer HMP HMP: Health Monitoring Programme Andrea Micheli.
National Cancer Registry Luxembourg EUROCHIP-3 Meeting Ispra, 27 th February 2012 Olivier Collignon, PhD, Sophie Couffignal, MD, CRP-Santé.
European Society for Quality in Healthcare European Society for Quality in Healthcare Founded 1998 to –promote communication between the stakeholders in.
Cancer inequalities in Europe UKACR & NCIN Conference, 17/18 June 2010 Dr. Andrea Micheli Director Descriptive Study and Health Planning Unit Fondazione.
Cervical cancer screening problems and barriers in Latvia
EUROCHIP-3 Cancer Health Information Project DG SANCO EC Health Programmes from local actions to common actions: the EU pillars of EU cancer control for.
Cancer inequalities in Europe Kielce, Polish conference on cancer, 13/15 June 2011 Dr. Andrea Micheli Director Descriptive Study and Health Planning Unit.
EUROCHIP - EUROpean Cancer Health Indicators Project A project supported by the European Commission Andrea Micheli 1, Paolo Baili 1, Carmen Martinez 2,
EUROCHIP-2 European Public Health Action on Cervical Cancer Screening GRELL Palma de Majorca Public Health Program EUROPEAN COMMISSION: HEALTH &
Information network on rare cancers RARECARENet Annalisa Trama, Gemma Gatta Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (Italy)
1 EUROPA DONNA – The European Breast Cancer Coalition Susan Knox, Executive Director KEEPING BREAST CANCER ON THE EUROPEAN HEALTH AGENDA.
SPHERE: EPHA Extraordinary General Assembly SPHERE Strengthening Public Health Research in Europe Science Europe Health Gabrielle Harvey Mark.
Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS.
DISCUSSIONS and DECISIONS Sophia, 22 nd May 2006 Public Health Program EUROPEAN COMMISSION: HEALTH & CONSUMER PROTECTION DIRECTORATE - GENERAL
Criteria for Centres of Expertise for Rare Diseases in the EU following EUCERD Recommendations RARECARENet Project: Consensus meeting on.
NOT ALL PAST SUCCESSES IN CANCER RESEARCH HAVE BEEN FOLLOWED BY ACTIONS EUROCHIP-2 THE ACTION Project & news EUROCHIP-2 THE ACTION Project & news Public.
“Working Together, Reducing Cancer, Saving Lives”
South-East European Cooperation Process ROMANIA South-East European Cooperation Process (SEECP)
Work Package 5 Information on centres of expertise for rare cancers WP leader: Sabine Siesling.
Objectives of Work Package 5 objectives for today Information on centres of expertise for rare cancers WP leader: Sabine Siesling.
DISCUSSION. EUROCHIP-2 ACTION PLAN COUNTRY 1COUNTRY 2COUNTRY 3 COUNTRY 30 ACTION1ACTION1 ACTION2ACTION2 ACTION3ACTION3 ACTION3ACTION3 ACTION4ACTION4 ACTION4ACTION4.
1 Cervical cancer screening in Lithuania 2005 Maiori, Italy Juozas Kurtinaitis Institute of Oncology, Vilnius University
EUROCHIP-2 ACTIVITY ON CERVICAL CANCER SCREENING BULGARIA.
Information network on rare cancers RARECARENet Annalisa Trama, Gemma Gatta Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (Italy)
1 "Cancer and the European Citizen – it’s time to deliver! Francesco De Lorenzo ECPC President ECPC Members in Action Conference 2009 ALL CANCER PATIENTS.
EUROCHIP-2 EUROCHIP-2 - The Action Public Health Program EUROPEAN COMMISSION: HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL.
European Commission Camilla SANDVIK DG SANCO / G/ 3 The European Union and Nutrition Presentation at European Health Forum, Gastein 26 September 2002 Camilla.
Organization and guideline development April 2010 ACCC The Netherlands.
Public Health Executive Agency Health Programme and HLY.
Presenter: U. Rothe/ U. Manuwald Institution: 3 rd WP7 meeting Istituto Superiore di Sanità, Roma July, 2-3, 2015 Questionnaire on Prevention and Management.
A Strategic Research Agenda for Europe in the field of illicit drugs Priorities for socio-economic and humanities research HDG Brussels - December 10,
European Union against cancer The EUROCHIP project 1st International Cancer Control Congress Vancouver, October 2005 Public Health Program EUROPEAN.
DETERMINE Working document # 4 'Economic arguments for addressing social determinants of health inequalities' December 2009 Owen Metcalfe & Teresa Lavin.
HTA Benefits and Risks Dr Bernard Merkel European Commission.
Information network on rare cancers Work Package 4 Information on epidemiology of rare cancers Riccardo Capocaccia and Sandra Mallone Cancer Epidemiology.
EUROCHIP-Italia in EUROCHIP-2 Health Indicators for Monitoring Cancer in Europe Public Health Program EUROPEAN COMMISSION: HEALTH & CONSUMER PROTECTION.
Dr Andrea Micheli Descriptive Epidemiology and Health Planning Unit Fondazione IRCCS “Istituto Nazionale dei Tumori” Milan Public Health Programme EUROPEAN.
The ERA-NET TRANSCAN-2, in continuity with the preceding ERA-NET TRANSCAN, aims at linking translational cancer research funding programmes in 15 Member.
Health Indicators in the European Union transforming health data to health information ECHIM Joint Action Jürgen Thelen EHIS Workshop
Cancer inequalities in Europe UKACR & NCIN Conference, 17/18 June 2010 Dr. Andrea Micheli Director Descriptive Study and Health Planning Unit Fondazione.
1 ECPC PAPER ON BLADDER CANCER FRANCESCO DE LORENZO Brussels, 20 April 2016.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.
The Cancer Registry of Norway Jan F Nygård Head of the IT-department.
The EEA Grants: Public Health Initiatives Programme Operator Meeting, Lisboa, 5 June 2014 National Health Examination Survey INSEF Carlos Matias.
National Information Day Greece 23 July 2015 Funding priorities under the work plan 2015.
Early DETECTion and integrated management of TuBerculosis in europe: E-DETECT TB Professor Ibrahim Abubakar Director, Institute for Global Health University.
Helena Silfverhielm, Chair PPHS EG Arnoldas Jurgutis, ITA PPHS EG NDPHS EXPERT GROUP ON PRIMARY HEALTH AND PRISON HEALTH CARE SYSTEMS Activities to implement.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.
Third EU Health Programme National Info day Athens, 21 April 2016 Courtesy of Irène Athanassoudis DG SANTE.
EUNetPaS European Union Network for Patient Safety
Janusz Sierosławski, Jacek Moskalewicz
Musculoskeletal Health in Europe
WP 4 – EPIDEMIOLOGY GEMMA Gatta
EU Reference Centres for Animal Welfare
Network Director European Health Futures Forum
Tit Albreht | Brussels | 7 November 2017
STEERING COMMITTEE MEETING
The Joint Action on Health Information InfAct
Dr Timothy Armstrong Coordinator
Presentation transcript:

THE EUROCHIP PROJECTS Health Indicators for Health Indicators for Monitoring Cancer in Europe

1.development of a list of cancer health indicators 2.using indicators to promote actions for cancer control 3.promoting common view of cancer plan: collaborative actions 4.to help the development of the European Health Information System By consensus conferences involving cancer experts of EU institutes, organisations and cancer networks EUROCHIP EUROCHIP EUROCHIP

Steering Committee Working Team Operational work Panel of Experts Methodological Group GS: Groups of specialists GS GS care and treatment GS GSGS GS EUROCHIP: THE ORGANISATION Steering Commitee from: Spain United Kingdom Switzerland Bulgaria Italy GS Screening Panel of Experts with representatives of all EU Member States

INDICATOR A INDICATOR B INDICATOR C. INDICATOR Z INDICATOR A INDICATOR B INDICATOR C. INDICATOR Z INFORMATION ANALYSIS ACTIONS

EUROCHIP-1 ( ) The EUROCHIP Network draws the list of Cancer Health Indicators recommended for collection in the participating EU 15 MS

Tobacco Alcohol Fruit and vegetables Sun radiation Occupational carcinogens BMI & Physical activity Stage at diagnosis Incidence Survival Prevalence Mortality & PYLL Organised screening coverage % with mammography % with cervical cytology exam % with colorectal cancer screening test Radiation equipments CTS Palliative radiotherapy Delay of cancer treatment Compliance with guidelines GDP Total Health expenditure Public health expenditure Anti-tobacco regulations EUROCHIP INDICATORS Prevention Socio-economic indicators Care & Treatment Screening 1. Outcome 2. Health determinants 3. Health system indicators

EUROCHIP-2 ( ) The EUROCHIP 2 The ACTION project implements actions to fill the gaps emerged in the EU Information System

THE EUROCHIP-2 THE ACTION PROJECT It is a translational research project (from epidemiology to public health) It is a project against disparities It is EC project It aims to research ways to promote health Its goal are to promote public health actions against cancer in each EU country It works to build an European platform for cancer control

Three indicators: “Stage at diagnosis”, “Delay of cancer treatment” and “Compliance with guidelines” EUROCHIP-2 Pilot Studies are feasibility studies in cancer registries of 10 countries They are performed to address the following questions: is it possible to collect these indicators at population level? is the information already available? from which sources can (or could) the data be obtained? EUROCHIP pilot studies refer to breast and colorectal cancer AIM: TO IMPROVE THE CANCER INFORMATION SYSTEM PILLAR 1

BULGARIA: assessment surveys on information level standard of cytological labs ROMANIA: assessment study shows high difficulties to implement screening in the near future In 2007 legislative changes were initiated on cervical screening LATVIA Workgroup of Latvian oncologists, gynaecologists, GP, stakeholders and health planners 2 informative documents were submitted to the MoH Screening expected to start in 2009 ESTONIA: cervical screening limits are low adherence, no screening registry, lack of reference laboratory LITHUANIA: a study was organized to evaluate results of the centralized invitation system in one municipality in Lithuania. It provides evidence and benefits of this system PILLAR 2 AIM: TO AVOID AVOIDABLE DEATHS LATVIA Workgroup of Latvian oncologists, gynaecologists, GP, stakeholders and health planners 2 informative documents were submitted to the MoH Screening expected to start in 2009 LITHUANIA: a study was organized to evaluate results of the centralized invitation system in one municipality in Lithuania. It provides evidence and benefits of this system

PILLAR 3 AIM: TO IMPROVE THE CANCER REGISTRATION  Activities in two countries without cancer registration: Greece and Luxembourg  Recommendations to the Network of Competent Authorities in support of cancer registration in Europe  Educational activity: EUROCHIP-2 sponsored in 2006 the participation of 9 researchers from Eastern European countries to the course “Cancer survival: principles, methods and applications” (London, 3-7 April 2006)

EUROCHIP-3 ( ) EUROCHIP-3 Common Action funded by the EC's Directorate for "Health and Consumer Protection" (DG SANCO) in the strand Health Information of the Work Plan of the Community Action in the Field of Health

EUROCHIP-3 MANDATE: Actions for the reduction of the inequalities in Cancer Health information systems in the EU Member States as shown by previous EUROCHIP projects MISSION : solidariety in EU cancer control METHOD : Multidisciplinary Consensus Conference of cancer control stakeholders coordinated at the National Institute for Cancer INT, Milan with the support of the European School of Oncology for the dissemination of results EUROCHIP is a 10 year network of over 100 representatives from International Organizations, Patient Associations and Member States delegates from the 27 EU member States

EUROCHIP-3 4 INTERNATIONAL WORK PACKAGES covering key cancer control areas: 1.EPIDEMIOLOGY 2.SCREENING 3.REHABILITATION 4.MACROECONOMICS 4 INSTITUTES IN: 1.THE NETHERLANDS 2.FINLAND 3.ESTONIA 4.ITALY SCIENTIFIC FOCUSES:

EUROCHIP-3 WPS 1. WP EPIDEMIOLOGY: Promotion of the collection of Cancer Indicators on diagnostic and treatment delay, implementation of EUROCHIP indicators in the EU, implementation of registries in Greece and Luxembourg (conducted at the IKNO, the Netherlands) 2. WP SCREENING: Communication to stakeholders on effective cervical cancer screening programmes and analysis, validation, and optimisation of invitation for cervical cancer screening in 5 Eastern European Countries (conducted at the Mass Screening Registry, Finland) 3. WP REHABILITATION: Identification of Cancer Health Indicators on psicho-social rehabilitation (conducted at the NIHD, Estonia) 4. WP MACROECONOMICS: Study on cancer costs and outcome (conducted by INT and AIFA?)

THE EUROCHIP NETWORK: TO IMPROVE CANCER CONTROL ACROSS EUROPE  MEPs Against Cancer (MAC) Meeting “Making Cancer Control a Priority” (Bruxelles, 27 June 2007)  EUROCHIP provided info, and helped the diffusion of the recommendations of the Portuguese EU Presidency “Health Strategies in Europe” conference (Lisbon, July 2007)  EUROCHIP in the steering committee of the 2nd International Cancer Control Congress (Rio De Janeiro, Nov 2007)  Cancer Control Chapters in:  “Cancer information” (Slovenian EU Presidency book)  “Cancer” (EUGLOREH Project)  “Cancer in Europe. The EUROCHIP projects” (DG SANCO’s Report on Major and Chronic Diseases)  EUROCHIP organized the 3rd International Cancer Control Congress (Cernobbio, Nov 2009)